At ASCO 2026 Dr Claudia Marchetti talks to ecancer about findings from a randomised pilot study evaluating short-term fasting alongside neoadjuvant chemotherapy in women with advanced high-grade serous ovarian cancer.

Short-term fasting was associated with improved pathological response, prolonged progression-free survival, and favourable metabolic and immune changes compared with a free diet, supporting further evaluation in larger clinical trials.